The global biosimulation market is on track for significant expansion, with a projected value of USD 11.24 billion by 2030, according to a recent market analysis. This represents a remarkable growth of 16.7% CAGR from 2023, indicating the increasing adoption and value placed on biosimulation across various industries. Biosimulation leverages computational modeling and simulation techniques to...

The global cardiovascular information system market is projected to experience significant growth, with an expected value of USD 14.96 billion by the year 2030. Recent market analysis indicates that the market size for cardiovascular information systems was valued at USD 8.20 billion in 2022, reflecting a steady upward trajectory with a Compound Annual Growth Rate (CAGR) of 7.8% over the...

The global personalized therapy biosimulation market size reached USD 1,061.7 Million in 2020 and is expected to register a revenue CAGR of 14.6%, during the forecast period, according to latest analysis by Emergen Research. Rising incidence of drug relapse and drug resistance cases and increasing application of quantitative system pharmacology in drug development processes are some...